Recovery of Cell Lines after use of Alemtuzumab for Induction Immunosuppression in Lung Transplant
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to determine if the recovery of cell lines is similar to what is described in the literature for other conditions, and that the patient that do require filgrastim for neutropenia are more likely to experience any form of rejection that patients that do not.
Description
The purpose of this study is to determine if the recovery of cell lines is similar to what is described in the literature for other conditions, and that the patient that do require filgrastim for neutropenia are more likely to experience any form of rejection that patients that do not.
Details
| Condition | Healthy |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX8027 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.